AI for drug discovery has enormous potential; to unlock it, we need to reset our mindset

The first Humira biosimilar in the US is here, but market penetration could be a challenge.

Gene Sullivan, Chief Product Strategy Officer at Insmed, explores how new thinking could improve the research process for rare disease treatments

How digital health technology can help clinical trials be more inclusive and accessible.

Groups of tiny glass frogs can sleep on a leaf in daylight and go entirely undetected by predators

Lawsuit from GenBioPro is the first of its kind – but other cases are likely to follow.

Download our free eBook to see what trends and innovations are shaping the industry’s future

Snapshots, sketches, and secrets of Lithuania’s burgeoning life sciences scene.

Our priorities paint a picture of who we are, and that’s as true in RNAi medicine development as it is elsewhere in life

An inside view on the French pharma company and Swiss NPO working on a treatment for a debilitating rare disease